{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T07:40:07Z","timestamp":1758958807152,"version":"3.44.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2024,9,23]],"date-time":"2024-09-23T00:00:00Z","timestamp":1727049600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,9,23]],"date-time":"2024-09-23T00:00:00Z","timestamp":1727049600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Double Thousand Plan","award":["jxsq2019201027"],"award-info":[{"award-number":["jxsq2019201027"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Biochem Genet"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1007\/s10528-024-10924-0","type":"journal-article","created":{"date-parts":[[2024,9,24]],"date-time":"2024-09-24T09:48:07Z","timestamp":1727171287000},"page":"4157-4178","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Prognostic Significance and Immune Landscape of an Efferocytosis-Related Gene Signature in Bladder Cancer"],"prefix":"10.1007","volume":"63","author":[{"given":"Fuchun","family":"Zheng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhipeng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qianxi","family":"Dong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sheng","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Situ","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuyang","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Songhui","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bin","family":"Fu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,9,23]]},"reference":[{"key":"10924_CR1","doi-asserted-by":"publisher","first-page":"148","DOI":"10.4081\/aiua.2021.2.148","volume":"93","author":"M Akg\u00fcl","year":"2021","unstructured":"Akg\u00fcl M, Baykan \u00d6, \u00c7a\u011fman Z, \u00d6zy\u00fcrek M, Tinay \u0130, Akbal C et al (2021) Gas6 expression and tyrosine kinase Axl Sky receptors: their relation with tumor stage and grade in patients with bladder cancer. Arch Ital Urol Androl Organo Uff Soc Ital Ecogr Urol E Nefrol 93:148\u2013152. https:\/\/doi.org\/10.4081\/aiua.2021.2.148","journal-title":"Arch Ital Urol Androl Organo Uff Soc Ital Ecogr Urol E Nefrol"},{"key":"10924_CR2","doi-asserted-by":"publisher","first-page":"1843","DOI":"10.3390\/cancers11121843","volume":"11","author":"N Al Kafri","year":"2019","unstructured":"Al Kafri N, Hafizi S (2019) Tumour-secreted protein S (ProS1) activates a Tyro3-Erk signalling axis and protects cancer cells from apoptosis. Cancers 11:1843. https:\/\/doi.org\/10.3390\/cancers11121843","journal-title":"Cancers"},{"key":"10924_CR3","doi-asserted-by":"publisher","first-page":"1080947","DOI":"10.3389\/fimmu.2022.1080947","volume":"13","author":"B An","year":"2022","unstructured":"An B, Guo Z, Wang J, Zhang C, Zhang G, Yan L (2022) Derivation and external validation of dendritic cell-related gene signatures for predicting prognosis and immunotherapy efficacy in bladder urothelial carcinoma. Front Immunol 13:1080947. https:\/\/doi.org\/10.3389\/fimmu.2022.1080947","journal-title":"Front Immunol"},{"key":"10924_CR4","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/S0140-6736(16)32455-2","volume":"389","author":"AV Balar","year":"2017","unstructured":"Balar AV, Galsky MD, Rosenberg JE, Powles T, Petrylak DP, Bellmunt J et al (2017) Atezolizumab as first-line treatment in cisplatin-ineligible patients with locally advanced and metastatic urothelial carcinoma: a single-arm, multicentre, phase 2 trial. Lancet Lond Engl 389:67\u201376. https:\/\/doi.org\/10.1016\/S0140-6736(16)32455-2","journal-title":"Lancet Lond Engl"},{"key":"10924_CR5","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1007\/978-3-030-73119-9_8","volume-title":"Tumor microenvironment: novel concepts","author":"HN Banerjee","year":"2021","unstructured":"Banerjee HN, Bartlett V, Krauss C, Aurelius C, Johnston K, Hedley J et al (2021) Efferocytosis and the story of \u201cFind Me\u201d, \u201cEat Me\u201d, and \u201cDon\u2019t Eat Me\u201d signaling in the tumor microenvironment. In: Birbrair A (ed) Tumor microenvironment: novel concepts. Springer International Publishing, Cham, pp 153\u2013162. https:\/\/doi.org\/10.1007\/978-3-030-73119-9_8"},{"key":"10924_CR6","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1016\/j.juro.2014.02.035","volume":"192","author":"CJ Beckham","year":"2014","unstructured":"Beckham CJ, Olsen J, Yin PN, Wu CH, Ting HJ, Hagen FK et al (2014) Bladder cancer exosomes contain EDIL-3\/Del1 and facilitate cancer progression. J Urol 192:583\u2013592. https:\/\/doi.org\/10.1016\/j.juro.2014.02.035","journal-title":"J Urol"},{"key":"10924_CR7","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1056\/NEJMoa1613683","volume":"376","author":"J Bellmunt","year":"2017","unstructured":"Bellmunt J, de Wit R, Vaughn DJ, Fradet Y, Lee J-L, Fong L et al (2017) Pembrolizumab as second-line therapy for advanced urothelial carcinoma. N Engl J Med 376:1015\u20131026. https:\/\/doi.org\/10.1056\/NEJMoa1613683","journal-title":"N Engl J Med"},{"key":"10924_CR8","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1038\/s41591-018-0014-x","volume":"24","author":"M Binnewies","year":"2018","unstructured":"Binnewies M, Roberts EW, Kersten K, Chan V, Fearon DF, Merad M et al (2018) Understanding the tumor immune microenvironment (TIME) for effective therapy. Nat Med 24:541\u2013550. https:\/\/doi.org\/10.1038\/s41591-018-0014-x","journal-title":"Nat Med"},{"key":"10924_CR9","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1200\/JCO.20.01665","volume":"39","author":"JWF Catto","year":"2021","unstructured":"Catto JWF, Gordon K, Collinson M, Poad H, Twiddy M, Johnson M et al (2021) Radical cystectomy against intravesical BCG for high-risk high-grade nonmuscle invasive bladder cancer: results from the randomized controlled BRAVO-feasibility study. J Clin Oncol off J Am Soc Clin Oncol 39:202\u2013214. https:\/\/doi.org\/10.1200\/JCO.20.01665","journal-title":"J Clin Oncol off J Am Soc Clin Oncol"},{"key":"10924_CR10","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1038\/s41419-021-04168-8","volume":"12","author":"S Chaudhary","year":"2021","unstructured":"Chaudhary S, Patidar A, Dhiman A, Chaubey GK, Dilawari R, Talukdar S et al (2021) Exposure of a specific pleioform of multifunctional glyceraldehyde 3-phosphate dehydrogenase initiates CD14-dependent clearance of apoptotic cells. Cell Death Dis 12:892. https:\/\/doi.org\/10.1038\/s41419-021-04168-8","journal-title":"Cell Death Dis"},{"key":"10924_CR11","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1080\/15548627.2022.2103961","volume":"19","author":"S Chouhan","year":"2023","unstructured":"Chouhan S, Sawant M, Weimholt C, Luo J, Sprung RW, Terrado M et al (2023) TNK2\/ACK1-mediated phosphorylation of ATP5F1A (ATP synthase F1 subunit alpha) selectively augments survival of prostate cancer while engendering mitochondrial vulnerability. Autophagy 19:1000\u20131025. https:\/\/doi.org\/10.1080\/15548627.2022.2103961","journal-title":"Autophagy"},{"key":"10924_CR12","doi-asserted-by":"publisher","first-page":"1035484","DOI":"10.3389\/fgene.2022.1035484","volume":"13","author":"J Fu","year":"2022","unstructured":"Fu J, Zhang W, Jiang T (2022) Immunogenic cell death mediation patterns reveal novel paradigm for characterizing the immune microenvironment and immunotherapeutic responses in bladder cancer. Front Genet 13:1035484. https:\/\/doi.org\/10.3389\/fgene.2022.1035484","journal-title":"Front Genet"},{"key":"10924_CR13","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1186\/s12935-014-0072-1","volume":"14","author":"J Gao","year":"2014","unstructured":"Gao J, Zhu Y, Nilsson M, Sundfeldt K (2014) TGF-\u03b2 isoforms induce EMT independent migration of ovarian cancer cells. Cancer Cell Int 14:72. https:\/\/doi.org\/10.1186\/s12935-014-0072-1","journal-title":"Cancer Cell Int"},{"key":"10924_CR14","doi-asserted-by":"publisher","first-page":"7614","DOI":"10.3390\/ijms24087614","volume":"24","author":"I Hanson","year":"2023","unstructured":"Hanson I, Pitman KE, Edin NFJ (2023) The role of TGF-\u03b23 in radiation response. Int J Mol Sci 24:7614. https:\/\/doi.org\/10.3390\/ijms24087614","journal-title":"Int J Mol Sci"},{"key":"10924_CR15","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1146\/annurev-cellbio-111315-125315","volume":"33","author":"PM Henson","year":"2017","unstructured":"Henson PM (2017) Cell removal: efferocytosis. Annu Rev Cell Dev Biol 33:127\u2013144. https:\/\/doi.org\/10.1146\/annurev-cellbio-111315-125315","journal-title":"Annu Rev Cell Dev Biol"},{"key":"10924_CR16","doi-asserted-by":"publisher","first-page":"328","DOI":"10.2174\/1574892818666230516143945","volume":"19","author":"Q Huang","year":"2024","unstructured":"Huang Q, Li Z, Liu C (2024) Prognostic value of fatty acid metabolism-related genes in patients with bladder cancer. Recent Patents Anticancer Drug Discov 19:328\u2013341. https:\/\/doi.org\/10.2174\/1574892818666230516143945","journal-title":"Recent Patents Anticancer Drug Discov"},{"key":"10924_CR17","doi-asserted-by":"publisher","first-page":"5435","DOI":"10.18632\/aging.205656","volume":"16","author":"Y Ji","year":"2024","unstructured":"Ji Y, Zuo C, Liao N, Yao L, Yang R, Chen H et al (2024) Identification of key lncRNAs in age-related macular degeneration through integrated bioinformatics and experimental validation. Aging 16:5435\u20135451. https:\/\/doi.org\/10.18632\/aging.205656","journal-title":"Aging"},{"key":"10924_CR18","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2020-001408","volume":"8","author":"M Lecoultre","year":"2020","unstructured":"Lecoultre M, Dutoit V, Walker PR (2020) Phagocytic function of tumor-associated macrophages as a key determinant of tumor progression control: a review. J Immunother Cancer 8:e001408. https:\/\/doi.org\/10.1136\/jitc-2020-001408","journal-title":"J Immunother Cancer"},{"key":"10924_CR19","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0241766","volume":"16","author":"YH Lee","year":"2021","unstructured":"Lee YH, Lee MM, De Silva DM, Roy A, Wright CE, Wong TK et al (2021) Autocrine signaling by receptor tyrosine kinases in urothelial carcinoma of the bladder. PLoS ONE 16:e0241766. https:\/\/doi.org\/10.1371\/journal.pone.0241766","journal-title":"PLoS ONE"},{"key":"10924_CR20","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1186\/1471-2407-14-93","volume":"14","author":"J Liu","year":"2014","unstructured":"Liu J, Kong C, Gong D, Zhang Z, Zhu Y (2014) PKC \u03b1 regulates netrin-1\/UNC5B-mediated survival pathway in bladder cancer. BMC Cancer 14:93. https:\/\/doi.org\/10.1186\/1471-2407-14-93","journal-title":"BMC Cancer"},{"issue":"3","key":"10924_CR21","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1038\/s41590-018-0292-y","volume":"20","author":"M Liu","year":"2019","unstructured":"Liu M, O\u2019Connor RS, Trefely S, Graham K, Snyder NW, Beatty GL (2019) Metabolic rewiring of macrophages by CpG potentiates clearance of cancer cells and overcomes tumor-expressed CD47\u2014mediated \u2018don\u2019t-eat-me\u2019signal. Nat Immunol 20(3):265\u2013275","journal-title":"Nat Immunol"},{"key":"10924_CR22","doi-asserted-by":"publisher","first-page":"2276371","DOI":"10.1080\/15592294.2023.2276371","volume":"18","author":"Z Lv","year":"2023","unstructured":"Lv Z, Gao W, Du Z, Zheng Y, Liu T, Hao C et al (2023) Alternative splicing of IRF3 plays an important role in the development of hepatocarcinoma. Epigenetics 18:2276371. https:\/\/doi.org\/10.1080\/15592294.2023.2276371","journal-title":"Epigenetics"},{"key":"10924_CR23","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s12894-023-01354-y","volume":"24","author":"J Ma","year":"2024","unstructured":"Ma J, Hu J, Zhao L, Wu Z, Li R, Deng W (2024) Identification of clinical prognostic factors and analysis of ferroptosis-related gene signatures in the bladder cancer immune microenvironment. BMC Urol 24:6. https:\/\/doi.org\/10.1186\/s12894-023-01354-y","journal-title":"BMC Urol"},{"key":"10924_CR24","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1038\/s41573-022-00470-y","volume":"21","author":"P Mehrotra","year":"2022","unstructured":"Mehrotra P, Ravichandran KS (2022) Drugging the efferocytosis process: concepts and opportunities. Nat Rev Drug Discov 21:601\u2013620. https:\/\/doi.org\/10.1038\/s41573-022-00470-y","journal-title":"Nat Rev Drug Discov"},{"key":"10924_CR25","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1038\/nrc2444","volume":"8","author":"C Murdoch","year":"2008","unstructured":"Murdoch C, Muthana M, Coffelt SB, Lewis CE (2008) The role of myeloid cells in the promotion of tumour angiogenesis. Nat Rev Cancer 8:618\u2013631. https:\/\/doi.org\/10.1038\/nrc2444","journal-title":"Nat Rev Cancer"},{"key":"10924_CR26","doi-asserted-by":"publisher","first-page":"3357","DOI":"10.1038\/s41467-023-38887-7","volume":"14","author":"T Nguyen","year":"2023","unstructured":"Nguyen T, Sridaran D, Chouhan S, Weimholt C, Wilson A, Luo J et al (2023) Histone H2A Lys130 acetylation epigenetically regulates androgen production in prostate cancer. Nat Commun 14:3357. https:\/\/doi.org\/10.1038\/s41467-023-38887-7","journal-title":"Nat Commun"},{"key":"10924_CR27","doi-asserted-by":"publisher","first-page":"404","DOI":"10.3322\/caac.21631","volume":"70","author":"VG Patel","year":"2020","unstructured":"Patel VG, Oh WK, Galsky MD (2020) Treatment of muscle-invasive and advanced bladder cancer in 2020. CA Cancer J Clin 70:404\u2013423. https:\/\/doi.org\/10.3322\/caac.21631","journal-title":"CA Cancer J Clin"},{"key":"10924_CR28","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1038\/nrc1256","volume":"4","author":"JW Pollard","year":"2004","unstructured":"Pollard JW (2004) Tumour-educated macrophages promote tumour progression and metastasis. Nat Rev Cancer 4:71\u201378. https:\/\/doi.org\/10.1038\/nrc1256","journal-title":"Nat Rev Cancer"},{"key":"10924_CR29","doi-asserted-by":"publisher","first-page":"20587","DOI":"10.1038\/srep20587","volume":"6","author":"X Qin","year":"2016","unstructured":"Qin X, Yan M, Zhang J, Wang X, Shen Z, Lv Z et al (2016) TGF\u03b23-mediated induction of Periostin facilitates head and neck cancer growth and is associated with metastasis. Sci Rep 6:20587. https:\/\/doi.org\/10.1038\/srep20587","journal-title":"Sci Rep"},{"key":"10924_CR30","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1158\/1078-0432.CCR-11-2271","volume":"18","author":"M Riester","year":"2012","unstructured":"Riester M, Taylor JM, Feifer A, Koppie T, Rosenberg JE, Downey RJ et al (2012) Combination of a novel gene expression signature with a clinical nomogram improves the prediction of survival in high-risk bladder cancer. Clin Cancer Res off J Am Assoc Cancer Res 18:1323\u20131333. https:\/\/doi.org\/10.1158\/1078-0432.CCR-11-2271","journal-title":"Clin Cancer Res off J Am Assoc Cancer Res"},{"key":"10924_CR31","doi-asserted-by":"publisher","first-page":"1971","DOI":"10.1007\/s00262-023-03376-9","volume":"72","author":"A Semeniuk-Wojta\u015b","year":"2023","unstructured":"Semeniuk-Wojta\u015b A, Podd\u0119bniak-Strama K, Modzelewska M, Bary\u0142a M, Dzi\u0105g-Dudek E, Syry\u0142o T et al (2023) Tumour microenvironment as a predictive factor for immunotherapy in non-muscle-invasive bladder cancer. Cancer Immunol Immunother CII 72:1971\u20131989. https:\/\/doi.org\/10.1007\/s00262-023-03376-9","journal-title":"Cancer Immunol Immunother CII"},{"key":"10924_CR32","doi-asserted-by":"publisher","first-page":"4312629","DOI":"10.1155\/2020\/4312629","volume":"2020","author":"C Shen","year":"2020","unstructured":"Shen C, Liu J, Wang J, Yang X, Niu H, Wang Y (2020) The analysis of PTPN6 for bladder cancer: an exploratory study based on TCGA. Dis Markers 2020:4312629. https:\/\/doi.org\/10.1155\/2020\/4312629","journal-title":"Dis Markers"},{"issue":"42","key":"10924_CR33","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1016\/j.ejca.2006.01.003","volume":"2006","author":"A Sica","year":"1990","unstructured":"Sica A, Schioppa T, Mantovani A, Allavena P (1990) Tumour-associated macrophages are a distinct M2 polarised population promoting tumour progression: potential targets of anti-cancer therapy. Eur J Cancer Oxf Engl 2006(42):717\u2013727. https:\/\/doi.org\/10.1016\/j.ejca.2006.01.003","journal-title":"Eur J Cancer Oxf Engl"},{"key":"10924_CR34","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21708","volume":"72","author":"RL Siegel","year":"2022","unstructured":"Siegel RL, Miller KD, Fuchs HE, Jemal A (2022) Cancer statistics, 2022. CA Cancer J Clin 72:7\u201333. https:\/\/doi.org\/10.3322\/caac.21708","journal-title":"CA Cancer J Clin"},{"key":"10924_CR35","doi-asserted-by":"publisher","first-page":"6929","DOI":"10.1038\/s41467-022-34724-5","volume":"13","author":"D Sridaran","year":"2022","unstructured":"Sridaran D, Chouhan S, Mahajan K, Renganathan A, Weimholt C, Bhagwat S et al (2022) Inhibiting ACK1-mediated phosphorylation of C-terminal Src kinase counteracts prostate cancer immune checkpoint blockade resistance. Nat Commun 13:6929. https:\/\/doi.org\/10.1038\/s41467-022-34724-5","journal-title":"Nat Commun"},{"key":"10924_CR36","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1038\/s41585-022-00578-1","volume":"19","author":"JYC Teoh","year":"2022","unstructured":"Teoh JYC, Kamat AM, Black PC, Grivas P, Shariat SF, Babjuk M (2022) Recurrence mechanisms of non-muscle-invasive bladder cancer\u2014a clinical perspective. Nat Rev Urol 19:280\u2013294. https:\/\/doi.org\/10.1038\/s41585-022-00578-1","journal-title":"Nat Rev Urol"},{"key":"10924_CR37","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1111\/1759-7714.13278","volume":"11","author":"M Wang","year":"2020","unstructured":"Wang M, Wang W, Ding J, Wang J, Zhang J (2020) Downregulation of Rab17 promotes cell proliferation and invasion in non-small cell lung cancer through STAT3\/HIF-1\u03b1\/VEGF signaling. Thorac Cancer 11:379\u2013388. https:\/\/doi.org\/10.1111\/1759-7714.13278","journal-title":"Thorac Cancer"},{"key":"10924_CR38","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.1038\/s41598-024-51158-9","volume":"14","author":"Y Wang","year":"2024","unstructured":"Wang Y, Tang Y, Liu Z, Tan X, Zou Y, Luo S et al (2024) Identification of an inflammation-related risk signature for prognosis and immunotherapeutic response prediction in bladder cancer. Sci Rep 14:1216. https:\/\/doi.org\/10.1038\/s41598-024-51158-9","journal-title":"Sci Rep"},{"key":"10924_CR39","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.1303","volume":"13","author":"C Wu","year":"2023","unstructured":"Wu C, Duan L, Li H, Liu X, Cai T, Yang Y et al (2023) PD1hi CD200hi CD4+ exhausted T cell increase immunotherapy resistance and tumour progression by promoting epithelial\u2013mesenchymal transition in bladder cancer. Clin Transl Med 13:e1303. https:\/\/doi.org\/10.1002\/ctm2.1303","journal-title":"Clin Transl Med"},{"key":"10924_CR40","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1007\/s11596-023-2762-1","volume":"43","author":"L Xiang","year":"2023","unstructured":"Xiang L, Rao Q, He B, Guo XH, Xu YD, Luo BP et al (2023) Role of Cyclin D1b in inducing macrophages toward a tumor-associated macrophage-like phenotype in murine breast cancer. Curr Med Sci 43:655\u2013667. https:\/\/doi.org\/10.1007\/s11596-023-2762-1","journal-title":"Curr Med Sci"},{"key":"10924_CR41","doi-asserted-by":"publisher","first-page":"1087246","DOI":"10.3389\/fgene.2022.1087246","volume":"13","author":"Y Xiao","year":"2022","unstructured":"Xiao Y, Xu D, Jiang C, Huili Y, Nie S, Zhu H et al (2022) Telomere maintenance-related genes are important for survival prediction and subtype identification in bladder cancer. Front Genet 13:1087246. https:\/\/doi.org\/10.3389\/fgene.2022.1087246","journal-title":"Front Genet"},{"key":"10924_CR42","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1002\/path.4515","volume":"236","author":"SH Xu","year":"2015","unstructured":"Xu SH, Huang JZ, Xu ML, Yu G, Yin XF, Chen D et al (2015) ACK1 promotes gastric cancer epithelial-mesenchymal transition and metastasis through AKT-POU2F1-ECD signalling. J Pathol 236:175\u2013185. https:\/\/doi.org\/10.1002\/path.4515","journal-title":"J Pathol"},{"key":"10924_CR43","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellsig.2023.110743","volume":"109","author":"Z Zeng","year":"2023","unstructured":"Zeng Z, Zhang Z, Cheng X, Yang H, Gong B, Zhou X et al (2023) Downregulation of RAB17 have a poor prognosis in kidney renal clear cell carcinoma and its expression correlates with DNA methylation and immune infiltration. Cell Signal 109:110743. https:\/\/doi.org\/10.1016\/j.cellsig.2023.110743","journal-title":"Cell Signal"},{"key":"10924_CR44","doi-asserted-by":"publisher","first-page":"2318413","DOI":"10.1080\/0886022X.2024.2318413","volume":"46","author":"Z Zhang","year":"2024","unstructured":"Zhang Z, Qiao Y, Ji J, Huang C, Shi H, Gan W et al (2024) The potential role of differentially expressed tRNA-derived fragments in high glucose-induced podocytes. Ren Fail 46:2318413. https:\/\/doi.org\/10.1080\/0886022X.2024.2318413","journal-title":"Ren Fail"},{"key":"10924_CR45","first-page":"1252","volume":"26","author":"F Zhao","year":"2021","unstructured":"Zhao F, Liu Y, Gu X, Zhang B, Song C, Cui B (2021) Identification of sixteen metabolic genes as potential biomarkers for colon adenocarcinoma. J BUON off J Balk Union Oncol 26:1252\u20131259","journal-title":"J BUON off J Balk Union Oncol"}],"container-title":["Biochemical Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10528-024-10924-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10528-024-10924-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10528-024-10924-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T07:13:46Z","timestamp":1758957226000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10528-024-10924-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,23]]},"references-count":45,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["10924"],"URL":"https:\/\/doi.org\/10.1007\/s10528-024-10924-0","relation":{},"ISSN":["0006-2928","1573-4927"],"issn-type":[{"type":"print","value":"0006-2928"},{"type":"electronic","value":"1573-4927"}],"subject":[],"published":{"date-parts":[[2024,9,23]]},"assertion":[{"value":"10 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 September 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 September 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"All organizations included in this study obtained ethical approval from the Ethics Committee of the First Affiliated Hospital of Nanchang University (Approval ID: (2022) CDYFYYLK (11-031)).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}},{"value":"Prior to participation, all patients were fully informed about the study\u2019s purpose, procedures, potential risks, and benefits. Written informed consent was obtained from each patient, ensuring that they understood and agreed to their involvement in the study. This process was conducted in accordance with the Declaration of Helsinki and relevant ethical guidelines.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed Consent"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}}]}}